Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
about
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasEffectiveness of plasma treatment on pancreatic cancer cells.CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysisResectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case.Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelSpatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerCross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing AnalysisKRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsOutcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stagesPathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Rare long-term survivors of pancreatic adenocarcinoma without curative resection.Portal vein stenosis after pancreatectomy following neoadjuvant chemoradiation therapy for pancreatic cancer.Pancreatic cancer: why is it so hard to treat?Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective StudyFriday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.Extended lymphadenectomy in patients with pancreatic cancer is debatable.Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm.Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?The importance of surgical margins in pancreatic cancer.Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma.Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature.Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen.Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer.Pathological and prognostic role of mdig in pancreatic cancerA new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas.Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options.Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma.
P2860
Q28075892-5456CE8F-7AC3-4565-94F6-0D9ECDC95486Q33466056-CFFA1D6D-F1F1-4722-8BBC-3DE385DFEEFEQ33814832-F9D3A232-DBC3-4CCC-8212-56010D238736Q33936746-6A161489-B6F1-4F59-842F-2DC1A4DDC3D1Q33957368-20403E46-FF1E-41E3-9B2C-1E638EB96DE6Q34634961-CB4AEBE9-D27B-4948-8041-F4CBA512EF29Q35147520-9E648445-ED08-4D16-9AA0-E87C9B3FEB6BQ35343764-739C8019-CFBC-47EC-BFD8-5A5E99A9420CQ35463399-FFE904AA-FC3E-44F4-8CA1-DF658693A904Q35498705-68552561-D6D2-4E40-9261-A758904DE2A0Q35522087-9052DFC4-7943-487C-8234-6797F9DC0E08Q35752711-72876BC9-583F-44C2-8848-5BF7521C3E0FQ35904643-06F0E907-957F-4D2F-9B2A-C1A00ED7A0A8Q36055277-83F3D5F8-FC8E-4BDD-9585-9EB283E646FFQ36401628-4A0FF3C4-5DCF-4CAF-B0C8-81AE09C97A4EQ36821676-CB2E75BF-2734-4751-8B12-114EA0AAE5FFQ36886497-C2A77EB8-54DC-4E6D-B8A1-CA3AC243A2C0Q37089422-B68BF8BD-9404-441C-9F26-ADB0ACD1CC0DQ37204959-070328E8-EE7A-418C-A4C8-9727E3ADDA85Q37480826-CDCB8760-DFA4-45FD-9546-6E5393B83CBDQ37688414-04A888BB-45EE-413B-B9BD-D8F0D2485164Q38106907-18AC0697-AD9F-4D77-B52A-C81B82BB9B49Q38165871-232AA912-4B90-4E9E-9B4E-3634CD2F61EDQ38177894-C153E235-AF30-4D72-A3A1-A0204281309BQ38604399-ABF06128-B600-4C03-8BB4-354431BC9996Q38646898-D5E34471-7416-4CB2-9135-3D42C8276A59Q38719146-23678AB4-4CE5-40C1-A0A7-2DE2B165F41EQ38726733-E283DC3A-BE16-42CB-84E2-6E2F919727DBQ38907944-3F7B7FD5-D230-4A8F-91EC-2BD778D8DCD8Q38927638-A551C346-404F-45E1-8BC6-4C84EC88474EQ38942566-C6BCB32A-0984-4C75-ACBD-381F49BE8EC6Q39023133-FBC18E40-7250-463F-B843-76EB628D564AQ39060622-11C9AEA5-AAD7-483C-9E6C-534950914C29Q40234593-1C72CA65-1ADB-45E5-B604-C1FD18063C69Q41590198-470D7040-E59C-4F94-B2BE-54F96E1DA34FQ41611442-82726059-F830-4B6F-88DE-8592190D009BQ41659333-0C32030D-2274-4A35-B8F4-39868AF0D09DQ42317099-02CEC06B-E720-4E05-B481-131516B6C26BQ43138752-06680BEA-9166-4AC1-A01B-C392191BFE3EQ44067402-EB1DB3DF-A576-471C-936E-2936D57A25B8
P2860
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@ast
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@en
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@nl
type
label
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@ast
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@en
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@nl
prefLabel
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@ast
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@en
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@nl
P2093
P2860
P1433
P1476
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure
@en
P2093
Andrew L Warshaw
Cristina R Ferrone
Gregory Y Lauwers
Jackye Szymonifka
Jennifer A Wargo
Jordan P Bloom
Keith D Lillemoe
Rafael Pieretti-Vanmarcke
Sarah P Thayer
P2860
P356
10.1016/J.SURG.2012.05.020
P407
P433
P577
2012-07-03T00:00:00Z